Search

Author/Creator Merino, O

11. P276 Influence of vedolizumab on extraintestinal manifestations in Inflammatory Bowel Disease: a nationwide multicenter study of the GETECCU Eneida registry. (27th May 2021)

Authors:
Pérez Galindo, P; Gisbert, J P; Carrillo-Palau, M; Bertoletti, F; González-Vivó, M; Ferrer, J A; Pajares, R; Merino, O; Castaño, A; Chaparro, M; Calvo, M; Barreiro-de-Acosta, M; Rodríguez, A; Lorente, R H; Algaba, A; Riado, D; Vela, M; De-la-Maza, S; Llaó, J; Vega, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. P309 Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study. (25th January 2019)

Authors:
Marín-Jiménez, I; Bastida, G; Forés, A; García-Planella, E; Argüelles-Arias, F; Sarasa, P; Tagarro, I; Fernández-Nistal, A; Montoto, C; Aguas, M; Santos-Fernández, J; Boscá, M; Ferreiro-Iglesias, R; Merino, O; Aldeguer, X; Cortés, X; Sicilia, B; Mesonero, F; Barreiro-de Acosta, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S254
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. P357 Long-term outcomes of biologic therapy in Crohn's disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU. (27th May 2021)

Authors:
Rodríguez-Lago, I; Fernández-Clotet, A; Mesonero, F; García-Alonso, F J; Casanova, M J; Fernández-de la Varga, M; Cañete, F; de Castro, L; Gutiérrez, A; Sicilia, B; Cano, V; Merino, O; Riestra, S; González-Partida, I; Surís, G; Torrealba, L; Ferreiro-Iglesias, R; Castro, B; Márquez, L; Sobrino, A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S377
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. P410 Long-term persistence and safety of biological drugs in patients with Inflammatory Bowel Disease. Differences between women and men: SEXEII study of ENEIDA. (30th January 2023)

Authors:
Gargallo-Puyuelo, C; Ricard, E; Iborra, M; Iglesias-Flores, E; Vera Mendoza, I; De Francisco García, R; Calafat Sard, M; Minguez, M; Lopez- San Roman, A; Taxonera, C; Guardiola, J; Barrio, J; Laredo, V; De Castro, L; Gisbert, J; García-Lopez, S; García Planella, E; Martín Arranz, D; Calvet, X; Me...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i539
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. (25th January 2019)

Authors:
Calafat, M; Mañosa, M; Panes, J; Nos, P; Iglesias, E; Vera, I; López-Sanromán, A; Guardiola, J; Taxonera, C; Mínguez, M; Martín, M D; de Castro, L; Riestra, S; Rivero, M; García-Planella, E; Calvet, X; García-López, S; Andreu, M; Gomollón, F; Barrio, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. P439 Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry. (25th January 2019)

Authors:
Casanova, M J; Chaparro, M; Mínguez, M; Ricart, E; Taxonera, C; García-López, S; Guardiola, J; López-San Román, A; Iglesias, E; Beltrán, B; Sicilia, B; Vera, M I; Hinojosa, J; Riestra, S; Domènech, E; Calvet, X; Pérez-Calle, J L; Martín-Arranz, M D; Aldeguer, X; Rivero, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. P443 Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study). (25th January 2019)

Authors:
Sainz Arnau, E; Zabana, Y; Miguel, I; Fernández Clotet, A; Casanova, M J; Martín, M D; Picó, M D; Alfambra, E; Rodriguez, I; Muñoz, F; Domínguez, M; Iglesias, E; Busquets, D; Gutiérrez, A; Cañete, F; Nuñez, L; Taxonera, C; Beltrán, B; Camps, B; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. P505 Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry. (25th January 2019)

Authors:
Iborra, M; Beltrán, B; Fernández, A; Gutiérrez, A; Antolín, B; Huguet, J M; de Francisco, R; Merino, O; Carpio, D; García López, S; Mesonero, F; Mínguez, M; Ferreiro, R; Carbajo, A Y; Rivero, M; Chaparro, M; Piñero-Pérez, M C; Monfort i Miquel, D; Bujanda, L; García-Sepulcre, M F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. P625 Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis. (30th January 2023)

Authors:
Llaó, J; Martín-Arranz, E; Zabana, Y; Navarro-Llavat, M; Garcia-Planella, E; Busquets, D; Monfort, D; Pineda, J R; Gutiérrez, A; Villoria, A; Menchén, L; Bastida, G; García-Alonso, F J; Rivero, M; Chaparro, M; Riestra, S; Merino, O; Rodríguez-Lago, I; Barreiro-de-Acosta, M; Domènech Moral, E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i755
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗